In conclusion, we delineate a mechanistic link from chronic inflammation to failure of lipid homeostasis and lysosome-limited autophagy, identifying the IL-6/CERS axis as a key driver and therapeutic entry point of cancer-associated hepatic dysfunction. The gene discussed is IL6; the disease is cancer.